Clinical Trials in Georgia

Showing 1361-1380 of 19,050 trials

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

NCT07128615

The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subtypes).

Influenza A

AstraZeneca405 participantsStarted Sep 2025

Long Beach, California, United States • Rolling Hills Estates, California, United States • Hialeah, Florida, United States +11 more locations

RECRUITINGPhase 363 miles

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

NCT07412756

This study evaluates the safety and efficacy of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC in delaying the return of major depressive symptoms. The trial is divided into three periods as follows: a screening period that will last approximately 1 month, a treatment period that will last a minimum of 12 months, and the follow up period that will last approximately 2 months. The duration of study participation may vary and may be shortened if depression symptoms worsen or if withdrawal from the study occurs for any reason.

Depressive Disorder, Major

Eli Lilly and Company1,000 participantsStarted Feb 2026

Moorpark, California, United States • Orange, California, United States • New Haven, Connecticut, United States +183 more locations

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Find Trials by Condition in Georgia

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration

Neuroblastoma Biology Study

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT

Phenotype, Genotype and Biomarkers 2

Patient Reported Outcomes With WaveLight LASIK

A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes